FDA, a complicit partner in crimes and corrupt industry practices have resulted in an epidemic of preventable injuries and deaths. Continue reading →
America’s Healthcare Crisis–Part V–FDA Complicit in Crimes
Jerry Avorn
Specific Anticonvulsants Increase Suicide Risk
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions." Continue reading →
BIG PHARMA’s CRIME SPREE
Rather than having a deterrent effect, the number of Big Pharma high profile criminal settlements is increasing and the settlements are getting bigger. Continue reading →
Drug-induced Risk of Cardiac Death: NYS Advisory_APA Guidance
“Current users of typical and of atypical antipsychotic drugs had higher rates of sudden cardiac death than did nonusers of antipsychotic drugs.” NEJM 2009
Continue reading →
Evidence: Why you should never trust new wonder drugs
Pharmaceutical companies, much like the tobacco industry, have made fortunes by engaging in lies, deception, and illegal practices that are making people sick and causing premature deaths.
Role of Litigation in Defining Drug Risks_JAMA / BMJ
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known. Continue reading →
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
Continue reading →
Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
Continue reading →
Columbia Journalism Review–The Complicity of the Media in Drug Marketing
Columbia Journalism Review–The Complicity of the Media in Drug Marketing Wed, 27 Jul 2005 An excellent article in the Columbia Journalism Review examines pharmaceutical industry hype and the media’s role in helping that industry create false impressions about the safety and benefits . . . Continue reading →
Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options
Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options Tue, 16 Aug 2005 A series of current articles in The Wall Street Journal, the Journal of the American Medical Association (JAMA), and the New York Times describe the . . . Continue reading →
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden resignation of FDA Commissioner, Lester Crawford, after just two months in office, has prompted a bipartisan Senate investigation and requests both by the Senate committee . . . Continue reading →
FDA Standards – Good Enough for Government Work?
FDA Standards – Good Enough for Government Work? Fri, 23 Sep 2005 An essay in The New England Journal of Medicine, by Jerry Avorn, M.D., professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at . . . Continue reading →